Summary
From a mutagenized population of wildtype S49 T lymphoma cells, clones were generated that were resistant to the physiological effects of the potent inhibitor of nucleoside transport, 4-nitrobenzyl-6-thioinosine (NBMPR). NBMPR protected wildtype cells from the cytotoxic effects of a spectrum of nucleosides, whereas two mutant clones, KAB1 and KAB5, were still sensitive to nucleoside-mediated cytotoxicity in the presence of NBMPR. In addition, NBMPR prevented wildtype cells from surviving in hypoxanthine-amethopterin-thymidine containing medium, whereas KAB1 and KAB5 cells grew normally. Rapid sampling transport studies indicated that mutant cells, unlike wildtype parental cells, had acquired a substantial NBMPR-insensitive nucleoside transport component. Binding studies with [3H]NBMPR indicated that KAB5 cells were 70-75% deficient in the number of NBMPR binding sites, whereas KAB1 cells possessed a wildtype complement of NBMPR binding sites. The characterization of the KABl and KAB5 cell lines suggested that the NBMPR binding site in wildtype S49 cells is genetically distinguishable from the nucleoside carrier site.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Paterson, A. R. P. and Oliver, J. M. (1971) Can. J. Biochem. 49, 271–274.
Scholtissek, C. (1968) Biochim. Biophys. Acta 158, 435–447.
Pickard, M. A., Brown, R. R., Paul, B. and Paterson, A. R. P. (1973) Can. J. Biochem. 51, 666–672.
Cass, C. E., Gaudette, L. A. and Paterson, A. R. P. (1971) Biochim. Biophys. Acta 345, 1–10.
Wohlheuter, R. M., Marz, R. and Plagemann, P. G. W. (1978) J. Membrane Biol. 42, 247–264.
Dahlig-Harley, E., Eilam, Y., Paterson, A. R. P. and Cass, C. E. (1981) Biochem. J. 200, 295–305.
Plagemann, P. G. W. and Wohlheuter, R. M. (1984) Biochim. Biophys. Acta 773, 39–52.
Eilam, Y. and Cabantchik, Z. I. (1977) J. Cell Physiol. 89, 831–838.
Belt, J. A. (1983) Biochem. Biophys. Res. Commun. 110, 417–412.
Belt, J. A. (1983) Molec. Pharmacol. 24, 479–484.
Cass, C. E., Kolassa, N., Uehara, Y., Dahlig-Harley, E., Harley, E. R. and Paterson, A. R. P. (1981) Biochim. Biophys. Acta 649, 769–777.
Ullman, B., Cohen, A. and Martin, D. W., Jr. (1976) Cell 9, 205–211.
Ullman, B. (1983) J. Biol. Chem. 258, 523–528.
Aronow, B, Allen, K., Patrick, J., and Ullman, B. (1985) J. Biol. Chem. 260, 6226–6233.
Cohen, A., Ullman, B. and Martin, D. W., Jr. (1979) J. Biol. Chem. 254, 112–116.
Paterson, A. R. P., Jakobs, E. S., Harley, E. R., Cass, C. E. and Robins, M. J. (1983) in Development of Target Oriented Anticancer Drugs, (Chang, Y. C. and Goz, B., eds.) pp. 41–56, Raven Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Aronow, B., Ullman, B. (1986). Mutant Mouse Cells with Nitrobenzylthioinosine-Insensitive Nucleoside Transport Functions. In: Nyhan, W.L., Thompson, L.F., Watts, R.W.E. (eds) Purine and Pyrimidine Metabolism in Man V. Advances in Experimental Medicine and Biology, vol 195B. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-1248-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1248-2_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-1250-5
Online ISBN: 978-1-4684-1248-2
eBook Packages: Springer Book Archive